Argus analyst Kevin Heal raised the firm’s price target on Travelers to $234 from $188 and keeps a Buy rating on the shares. The company’s Q4 earnings were significantly higher than expected due to materially lower catastrophe losses than the previous year, a higher underwriting gain and growth in net investment income, the analyst tells investors in a research note. Argus adds that margins at Travelers should improve as the company raises prices on auto and homeowners’ insurance while maintaining current retention rates and as it expands its data analytics and digital initiatives.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TRV:
- Travelers price target raised to $210 from $185 at RBC Capital
- Travelers price target raised to $240 from $230 at Roth MKM
- Early notable gainers among liquid option names on January 19th
- The Travelers Companies (NYSE:TRV) Soars on Impressive Q4 Numbers
- Options Volatility and Implied Earnings Moves Today, January 19, 2024